NHS (National Health Service) cervical screening frequency/range "correct":
This article was originally published in Clinica
Last year's decision by the UK to reduce the cervical screening call-up interval among women aged 25-49, from five years to three, will substantially reduce the incidence of the disease. So suggest the results of a modelling study by Cancer Research UK and Julietta Patnick, director of the NHS cancer screening programmes. The research published in the British Journal of Cancer (August 2004) shows an 18% fall in cumulative lifetime incidence, compared with pre-2003 policy, and a reduction in the predicted lifetime incidence of invasive cervical cancer, from 0.77% (under pre-2003 policy) to 0.63%, compared with a 1.70% predicted incidence without screening. The research also found that continuing to screen the 20-25 age group would have had minimal impact. A five-year screening interval was retained for women aged 50-64 years.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.